At issue is the AIDS drug abacavir, also known by the brand name Ziagen, which is found in compound drugs known as Trizivir and Epzicom. ...
Despite competition from GlaxoSmithKline's (NYSE:GSK) GSK Trizivir and Abbott Laboratories (NYSE:ABT) ' ABT Lopinavir, Gilead's HIV treatments continued to ...
GlaxoSmithKline recently withdrew the patent applications for its antiretroviral drugs Abacavir and Trizivir in India, the Economic Times reports. ...
While British drug maker GSK withdrew its application for a combination AIDs drug called Trizivir, US drug major Eli Lilly & Co voluntarily withdrew its ...
While British drug maker GSK withdrew its application for a combination AIDs drug called Trizivir, US drug major Eli Lilly & Co voluntarily withdrew its ...
While GSK had withdrawn its Indian patent applications for two of its antiretroviral combination drugs, combivir and trizivir, used to combat HIV/AIDS, ...
all 44 news articles
GlaxoSmithKline recently withdrew the patent applications for its antiretroviral drugs Abacavir and Trizivir in India, the Economic Times reports. ...
It is believed that the company formally withdrew the application of Abacavir, however, the other drug of the company, namely, Trizivir, is believed to be ...
While GSK has formally withdrawn the application of Abacavir, it is learnt that the UK giant’s other drug, Trizivir, is deemed withdrawn after it made a ...